Global Ablation Technologies Market Expected to Reach $4.73 Billion by 2021 - Rising Incidence of Atrial Fibrillation Across the Globe - Research and Markets

DUBLIN, Mar 22, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Ablation Technologies Market by Product & Application - Global Forecasts to 2021" report to their offering.

The global ablation technology market is estimated to be valued at USD 2.82 Billion in 2016, growing at a CAGR of 10.9% between 2016 and 2021 and reach USD 4.73 Billion.

On the basis of type, the market is categorized into laser/light, radiofrequency, ultrasound, electrical, cryoablation, microwave, and hydrothermal ablation technology. The radiofrequency ablation segment is estimated to command the largest share of the global market in 2016 due to lower cost of radiofrequency ablation procedures as compared to other ablation techniques coupled with its high safety, efficacy, and short procedural duration for the treatment of cancer, atrial fibrillation, and pain management.

Based on products, the market is segmented into light/laser ablators, radiofrequency ablators, ultrasound ablators, electrical ablators, cryoablation devices, microwave ablators, and hydrothermal ablators. The microwave ablators segment is estimated to grow at the highest CAGR from 2016 to 2021. High success rate of microwave ablation in cancer treatment, as well as advantages offered by it over RF ablation (such as, microwave ablation devices can produce larger ablation zones and do not suffer as much from the heat sink effect that can handicap RF ablation), form the major factors contributing to the growth of this segment.

By application, the market is further segmented into cardiovascular disease, pain management, cancer, ophthalmology, cosmetic surgery, gynecology, urology, orthopedics, and others. The cardiovascular disease segment is estimated to account for the largest share of the market in 2016. Rising incidence of atrial fibrillation across the globe coupled with the development of novel ablation technology for the treatment of atrial fibrillation is the major factor driving the growth of the market.

Companies Mentioned

• Angiodynamics, Inc.
• Atricure, Inc.
• Biosense Webster, Inc. (A Subsidiary of Johnson & Johnson Inc.)
• Boston Scientific Corporation
• Conmed Corporation
• Galil Medical Inc. (Acquired By BTG International Ltd.)
• Medtronic PLC
• Olympus Corporation
• Smith & Nephew
• St. Jude Medical, Inc.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Trends

7 Global Ablation Technology Market, By Type

8 Global Ablation Technology Market, By Product 

9 Global Ablation Technology Market, By Application

10 Global Ablation Technology Market, By Region

11 Competitive Landscape

12 Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/nfdrxm/ablation

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets